Chemed (CHE) Capital Expenditures (2009 - 2026)

Chemed's Capital Expenditures history runs 18 years deep, the most recent figure standing at $17.1 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 28.89% year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $66.6 million (up 31.56% YoY), while the FY2025 annual figure was $62.8 million, up 26.78% from the prior year.
• Capital Expenditures was $17.1 million for Q1 2026 at Chemed, up from $16.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $18.3 million in Q4 2022 to a low of $11.1 million in Q2 2024.
• Historically, Capital Expenditures has averaged $14.3 million across 5 years, with a median of $13.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Capital Expenditures plunged 35.49% in 2023, then surged 42.9% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $18.3 million in 2022, then slumped by 35.49% to $11.8 million in 2023, then advanced by 8.34% to $12.8 million in 2024, then rose by 28.11% to $16.3 million in 2025, then advanced by 4.7% to $17.1 million in 2026.
• The last three Capital Expenditures figures came in at $17.1 million (Q1 2026), $16.3 million (Q4 2025), and $17.4 million (Q3 2025), per Business Quant data.